2,722 Shares in Silicon Laboratories, Inc. $SLAB Purchased by Counterpoint Mutual Funds LLC

Key Points

• Counterpoint Mutual Funds LLC purchased a new stake in Silicon Laboratories, Inc., acquiring 2,722 shares valued at approximately $401,000.
• Several hedge funds increased their positions in Silicon Laboratories, with notable increases from Cetera Investment Advisers and UBS AM.
• Wall Street analysts have mixed ratings for Silicon Laboratories, with a consensus rating of "Moderate Buy" and an average target price of $151.13.

Counterpoint Mutual Funds LLC bought a new stake in Silicon Laboratories, Inc. (NASDAQ:SLAB - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 2,722 shares of the semiconductor company's stock, valued at approximately $401,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Cetera Investment Advisers raised its position in Silicon Laboratories by 14.2% in the 4th quarter. Cetera Investment Advisers now owns 2,917 shares of the semiconductor company's stock worth $362,000 after buying an additional 362 shares during the last quarter. Millennium Management LLC increased its holdings in Silicon Laboratories by 27.3% in the 4th quarter. Millennium Management LLC now owns 3,438 shares of the semiconductor company's stock valued at $427,000 after acquiring an additional 738 shares during the last quarter. Quantinno Capital Management LP purchased a new stake in shares of Silicon Laboratories during the 4th quarter worth approximately $250,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Silicon Laboratories by 18.0% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 95,477 shares of the semiconductor company's stock worth $11,860,000 after purchasing an additional 14,552 shares during the period. Finally, Jefferies Financial Group Inc. bought a new stake in Silicon Laboratories in the fourth quarter worth about $1,303,000.

Wall Street Analysts Forecast Growth

A number of research firms have commented on SLAB. Morgan Stanley cut their target price on shares of Silicon Laboratories from $157.00 to $144.00 and set an "equal weight" rating on the stock in a research report on Wednesday, August 6th. Benchmark reaffirmed a "buy" rating and set a $160.00 target price on shares of Silicon Laboratories in a report on Tuesday, May 27th. Barclays boosted their price objective on Silicon Laboratories from $100.00 to $130.00 and gave the stock an "equal weight" rating in a research note on Tuesday, August 5th. Stifel Nicolaus boosted their target price on shares of Silicon Laboratories from $144.00 to $160.00 and gave the company a "buy" rating in a report on Friday, July 18th. Finally, KeyCorp lifted their price objective on Silicon Laboratories from $160.00 to $180.00 and gave the company an "overweight" rating in a research note on Tuesday, July 8th. Five analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $151.13.

Insider Buying and Selling

In related news, SVP Brandon Tolany sold 8,000 shares of the stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $145.23, for a total transaction of $1,161,840.00. Following the sale, the senior vice president owned 62,328 shares in the company, valued at approximately $9,051,895.44. This trade represents a 11.38% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders sold a total of 12,070 shares of company stock valued at $1,703,472 over the last three months. 1.60% of the stock is owned by insiders.

Silicon Laboratories Trading Down 2.5%

NASDAQ SLAB opened at $133.51 on Wednesday. Silicon Laboratories, Inc. has a 1-year low of $82.82 and a 1-year high of $160.00. The stock's 50 day moving average is $135.16 and its two-hundred day moving average is $126.31. The company has a market capitalization of $4.38 billion, a price-to-earnings ratio of -41.46 and a beta of 1.52.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last released its earnings results on Tuesday, August 5th. The semiconductor company reported $0.11 EPS for the quarter, beating the consensus estimate of $0.09 by $0.02. Silicon Laboratories had a negative return on equity of 7.21% and a negative net margin of 14.88%.The company had revenue of $192.85 million during the quarter, compared to analysts' expectations of $192.57 million. During the same period last year, the firm earned ($0.56) EPS. The business's revenue for the quarter was up 32.6% on a year-over-year basis. Silicon Laboratories has set its Q3 2025 guidance at 0.200-0.400 EPS. On average, analysts predict that Silicon Laboratories, Inc. will post -0.97 earnings per share for the current year.

About Silicon Laboratories

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.